Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Apex Biotechnology Corp. (1733) Income Statement

Apex Biotechnology Corp. Income Statement

Last quarter (Q2 2026), Apex Biotechnology Corp.'s total revenue was NT$470.65M, a decrease of 7.71% from the same quarter last year. In Q2, Apex Biotechnology Corp.'s net income was NT$36.85M. See Apex Biotechnology Corp.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 1.94BNT$ 1.85BNT$ 1.68BNT$ 2.24BNT$ 2.13B
NT$ 538.74MNT$ 521.34MNT$ 531.12MNT$ 576.84MNT$ 571.51M
NT$ 398.01MNT$ 392.83MNT$ 389.40MNT$ 400.28MNT$ 370.06M
Depreciation and AmortizationNT$ 60.93MNT$ 64.81MNT$ 75.71MNT$ 94.10MNT$ 95.67M
NT$ 201.65MNT$ 221.58MNT$ 221.06MNT$ 299.07MNT$ 289.65M
NT$ 140.73MNT$ 128.51MNT$ 141.72MNT$ 204.97MNT$ 193.97M
NT$ 49.17MNT$ 24.62MNT$ -754.00KNT$ 23.02MNT$ -16.52M
NT$ 189.90MNT$ 153.13MNT$ 140.96MNT$ 199.57MNT$ 184.94M
NT$ 163.04MNT$ 128.00MNT$ 115.78MNT$ 181.78MNT$ 202.22M
Per Share Metrics
Basic EPSNT$ 1.63NT$ 1.28NT$ 1.16NT$ 1.82NT$ 2.03
Diluted EPSNT$ 1.63NT$ 1.27NT$ 1.15NT$ 1.81NT$ 1.93
Weighted Average Shares Outstanding100.02M100.22M99.81M99.95M99.73M
Weighted Average Shares Outstanding (Diluted)100.02M100.40M100.33M100.67M105.64M

Currency in TWD

Apex Biotechnology Corp. Earnings and Revenue History

0800M1.6B2.4B4 %6 %8 %10 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin